Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-20.39%Buyback Yield
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | -20.39% | $ 5.16M | $ 1.05M |
| 3/31/2025 | -62% | $ 5.79M | $ 3.59M |
| 12/31/2024 | -61.95% | $ 4.8M | $ 2.98M |
| 9/30/2024 | -44.25% | $ 6.73M | $ 2.98M |
| 6/30/2024 | -58.16% | $ 5.12M | $ 2.98M |
| 3/31/2024 | 0% | $ 4.32M | $ 0 |
| 12/31/2023 | -103.18% | $ 6.07M | $ 6.27M |
| 9/30/2023 | -60.53% | $ 10.35M | $ 6.27M |
| 6/30/2023 | -55.08% | $ 11.38M | $ 6.27M |
| 3/31/2023 | -55.85% | $ 11.22M | $ 6.27M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) Buyback Yield stands at 0%.
- Over the past 5 years, GT BIOPHARMA INC's average Buyback Yield has been -32.19%.
- The median Buyback Yield for GT BIOPHARMA INC during this period was -25.98%
- GT BIOPHARMA INC reached its highest Buyback Yield over the past 5 years at 0%.
- The lowest Buyback Yield recorded by GT BIOPHARMA INC in the same timeframe -103.18%
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for GT BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 0 ]) / Market Cap [ $ 14.32M ]
(=) Buyback Yield [ 0% ] GTBP - Buyback Yield, Last 5 years
-103.18%
Minimum
Dec 31, 2023
0%
Maximum
Sep 30, 2020
-32.19%
Average
-25.98%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.43% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |